PreComb develops technologies to optimally adapt the therapies to each patient for difficult to treat cancers.
PreComb has raised €2.0M across 2 funding rounds from 3 investors, most recently a Series A round in Dec 2024. Based in Hombrechtikon, Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2024-12-30 | Series A | — | — | View deal → |
| 2021-04-27 | Seed | €2.0M | FiveT Capital,High-Tech Gründerfonds,Kinled Austria | View deal → |
